Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Roa

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Molecular Medicine (Cambridge, Mass.)|October 5, 2011
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cellsCarlo Calissano, Rajendra N Damle, Sonia Marsilio, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Journal of Medicinal Chemistry|June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo EfficacyObdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Nature Communications|May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignanciesEdurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Molecular Medicine (Cambridge, Mass.)|October 5, 2011
Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born/divided and older/quiescent cellsCarlo Calissano, Rajendra N Damle, Sonia Marsilio, et al.
Blood|February 3, 2025
IL-10 from tumoral B cells modulates the diffuse large B-cell lymphoma microenvironment and response to immunotherapyMarcos Garcia-Lacarte, Sara C Grijalba, Javier Melchor Sánchez, et al.
Journal of Medicinal Chemistry|June 29, 2018
Discovery of Reversible DNA Methyltransferase and Lysine Methyltransferase G9a Inhibitors with Antitumoral in Vivo EfficacyObdulia Rabal, Edurne San José-Enériz, Xabier Agirre, et al.
Blood|April 13, 2019
PD-1/PD-L1 immune checkpoint and p53 loss facilitate tumor progression in activated B-cell diffuse large B-cell lymphomasMarién Pascual, María Mena-Varas, Eloy Francisco Robles, et al.
Nature Communications|May 27, 2017
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignanciesEdurne San José-Enériz, Xabier Agirre, Obdulia Rabal, et al.
The Journal of Pathology|February 22, 2018
Richter transformation driven by Epstein-Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemiaMaria J García-Barchino, Maria E Sarasquete, Carlos Panizo, et al.
Nature Medicine|March 17, 2023
Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myelomaMarta Larrayoz, Maria J Garcia-Barchino, Jon Celay, et al.
Nature Communications|June 15, 2016
Homeobox NKX2-3 promotes marginal-zone lymphomagenesis by activating B-cell receptor signalling and shaping lymphocyte dynamicsEloy F Robles, Maria Mena-Varas, Laura Barrio, et al.
Pageof 4